Literature DB >> 10192734

Involvement of the #12u lymph nodes around the upper lobe bronchi in patients with lung cancer of the right middle lobe, right lower lobe, or left lower lobe.

M Sato1, Y Saito, H Aikawa, A Sakurada, M Sagawa, T Tanita, T Kondo, S Fujimura.   

Abstract

In Japan, the lymph nodes around the upper lobe bronchi, known as the #12u nodes, are not included in the nodes recommended for dissection in patients with right middle lobe carcinoma, right lower lobe carcinoma, or left lower lobe carcinoma. However, histologic examination has revealed involvement of these nodes in pneumonectomy patients whose carcinoma originated in the right lower lobe. We histologically examined the lymph nodes from 152 patients with lung cancer to determine the incidence of involvement of the #12u lymph nodes. These nodes were found to be involved in 14 (9.2%) of the 152 patients. The rate of involvement was significantly higher in those with T2-T4 disease than in those with T1 disease, and was also significantly higher in patients with N2 disease than in those with N1 disease. There were two long-term survivors without recurrence, and one other patient who lived for more than 5 years before succumbing to the disease. In conclusion, to ensure removal of all the cancer tissue, it is recommended that the #12u lymph nodes be included in the nodes routinely dissected in patients with right lower lobe carcinoma, right middle lobe carcinoma, or left lower lobe carcinoma.

Entities:  

Mesh:

Year:  1999        PMID: 10192734     DOI: 10.1007/BF02483013

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  9 in total

1.  Mediastinal lymphatic pathways of the azygos and aortic arches: injection based on segments of the adult lung.

Authors:  M Riquet; P Dupont; G Hidden; B Debesse
Journal:  Surg Radiol Anat       Date:  1991       Impact factor: 1.246

2.  The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung. A commentary.

Authors:  T W Shields
Journal:  J Thorac Cardiovasc Surg       Date:  1990-01       Impact factor: 5.209

3.  Cervical venous anastomoses of pulmonary lymphatic vessels.

Authors:  F Le Pimpec Barthes; M Riquet; D Hartl; J P Hubsch; G Hidden
Journal:  Surg Radiol Anat       Date:  1997       Impact factor: 1.246

4.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

5.  Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults.

Authors:  M Riquet; G Hidden; B Debesse
Journal:  J Thorac Cardiovasc Surg       Date:  1989-04       Impact factor: 5.209

6.  The role of surgery in N2 lung cancer.

Authors:  N Martini; B J Flehinger
Journal:  Surg Clin North Am       Date:  1987-10       Impact factor: 2.741

7.  Anatomic basis of lymphatic spread of lung carcinoma to the mediastinum: anatomo-clinical correlations.

Authors:  M Riquet; D Manac'h; P Dupont; A Dujon; G Hidden; B Debesse
Journal:  Surg Radiol Anat       Date:  1994       Impact factor: 1.246

8.  Anatomic basis of lymphatic spread from carcinoma of the lung to the mediastinum: surgical and prognostic implications.

Authors:  M Riquet
Journal:  Surg Radiol Anat       Date:  1993       Impact factor: 1.246

9.  The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis.

Authors:  T Naruke; T Goya; R Tsuchiya; K Suemasu
Journal:  Ann Thorac Surg       Date:  1988-12       Impact factor: 4.330

  9 in total
  2 in total

1.  Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer.

Authors:  Hiroaki Kuroda; Yukinori Sakao; Mingyon Mun; Noriko Motoi; Yuichi Ishikawa; Ken Nakagawa; Yasushi Yatabe; Sakae Okumura
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  Risk factors of lobar lymph node metastases in non-primary tumor-bearing lobes among the patients of non-small-cell lung cancer.

Authors:  Jingwei Liu; Jian Li; Gang Lin; Zhiqiang Long; Qian Li; Bing Liu
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.